| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.33 |
3e-09 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-08 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.35 |
2e-07 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-07 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-05 |